Christopher Scott Hill
CIK: 0001641315
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Core Laboratories Inc. /DE/
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 12, 2026CLB
Core Laboratories Inc. /DE/
Award(A)DirectPerformance Shares
70K shares- - Dec 31, 2025CLB
Core Laboratories Inc. /DE/
Tax Payment(F)Direct32.2K shares at avg. $16.03$515K - Dec 31, 2025CLB
Core Laboratories Inc. /DE/
Exercise(M)Direct61.4K shares- - Feb 13, 2025CLB
Core Laboratories Inc. /DE/
Award(A)DirectPerformance Shares
68.8K shares- - Dec 31, 2024CLB
Core Laboratories Inc. /DE/
Tax Payment(F)Direct14.7K shares at avg. $17.31$255K - Dec 31, 2024CLB
Core Laboratories Inc. /DE/
Exercise(M)Direct23.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 12, 2026 | CLB Core Laboratories Inc. /DE/ | Award(A) Performance Shares | 70,008 | - | - | Direct |
| Dec 31, 2025 | CLB Core Laboratories Inc. /DE/ | Tax Payment(F) | 32,152 | $16.03 | $515,397 | Direct |
| Dec 31, 2025 | CLB Core Laboratories Inc. /DE/ | Exercise(M) | 61,417 | - | $0 | Direct |
| Feb 13, 2025 | CLB Core Laboratories Inc. /DE/ | Award(A) Performance Shares | 68,800 | - | - | Direct |
| Dec 31, 2024 | CLB Core Laboratories Inc. /DE/ | Tax Payment(F) | 14,719 | $17.31 | $254,786 | Direct |
| Dec 31, 2024 | CLB Core Laboratories Inc. /DE/ | Exercise(M) | 23,607 | - | $0 | Direct |
1-6 of 6 transactions
About Hill Christopher Scott
Hill Christopher Scott (SEC CIK 0001641315) files insider reports with the SEC as SVP & CFO of Core Laboratories Inc. /DE/ (CLB).
Signal8 holds 4 ownership filings by Hill Christopher Scott, all Form 4s, filed between Jan 3, 2025 and Feb 17, 2026. Those filings report 6 transactions, from Dec 31, 2024 to Feb 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hill Christopher Scott's filings is in HOUSTON, TX.
Recent filings by Hill Christopher Scott
- Feb 12, 2026: Grant or award of CLB derivative securities (Form 4, code A).
- Dec 31, 2025: Tax withholding of CLB shares (Form 4, code F).
- Dec 31, 2025: Option exercise of CLB shares (Form 4, code M).
- Feb 13, 2025: Grant or award of CLB derivative securities (Form 4, code A).
- Dec 31, 2024: Tax withholding of CLB shares (Form 4, code F).
Other insiders filing for Core Laboratories Inc. /DE/ (CLB)
- Tattoli Mark Damian, SVP, Gen Counsel & Secretary
- Teo Sow Hang, CAO & Treasurer
- Bruno Lawrence, Chairman and CEO
- Murray Katherine, Director
- ANASTASIO CURT, Director
- Klingensmith Harvey Robert, Director